HIV Testing Algorithm

<p>HIV Testing Algorithm</p

Diagnostic accuracy of the OraQuick HIV-1/2 rapid test performed on oral mucosal fluid specimens

<p>Sensitivity = 100% (95% CI 98, 100)</p><p>Specificity = 100% (95% CI 99, 100)</p><p>Positive predictive value = 100%</p><p>Negative predictive value = 100%</p><p>Positive likelihood ratio = NA</p><p>Negative likelihood ratio = 0</p

Testing algorithm and reference standard

*<p>If Western Blot was indeterminate, ELISA (enzyme-linked immuno-assay) was repeated on stored sera; if repeatedly indeterminate, the sequence was repeated with a fresh blood sample</p>*<p>Ref: CDC guidelines for rapid testing</p

Risk factors for unfavourable response at the end of treatment in new smear positive pulmonary TB patients [N = 1543].

<p>Risk factors for unfavourable response at the end of treatment in new smear positive pulmonary TB patients [N = 1543].</p

Treatment outcome of new smear positive pulmonary TB patients [N = 1565].

<p>Treatment outcome of new smear positive pulmonary TB patients [N = 1565].</p

Study sites for the recurrence of TB among the newly diagnosed sputum positive pulmonary TB patients treated under RNTCP in India.

<p>Study sites for the recurrence of TB among the newly diagnosed sputum positive pulmonary TB patients treated under RNTCP in India.</p

Status at 12 months after Treatment success in new smear positive pulmonary TB patients [N = 1210].

<p>Status at 12 months after Treatment success in new smear positive pulmonary TB patients [N = 1210].</p

Details on screening, enrolment and follow-up for TB recurrence in new smear positive pulmonary TB patients under RNTCP.

<p>Details on screening, enrolment and follow-up for TB recurrence in new smear positive pulmonary TB patients under RNTCP.</p

Details of TB recurrence in new smear positive pulmonary TB patients [N = 158].

<p>Details of TB recurrence in new smear positive pulmonary TB patients [N = 158].</p